Scholarlink

Background <p>Obesity significantly influences aortic valve calcification (AVC). However, the relationship between Metabolic Score for Visceral Fat (METS-VF), an indicator of visceral adiposity, and AVC remains largely unclear. Therefore, this study investigated the correlations between METS-VF with AVC prevalence, new-onset, and progression, as well as the causal association between visceral adipose tissue (VAT) and calcific aortic valve stenosis (CAVS).</p> Methods <p>The analysis included a cohort of 5,245 individuals drawn from the Multi-Ethnic Study of Atherosclerosis (MESA) database. Associations between baseline METS-VF and AVC prevalence, new-onset, and progression were analyzed through logistic regression and Cox regression. The potential causal link between the VAT and CAVS was evaluated by applying a two-sample Mendelian randomization (MR) strategy.</p> Results <p>The findings indicated that a one-unit increment in METS-VF correlates with a 41% increased risk of prevalent AVC in the fully adjusted model (odds ratio [OR] = 1.41; 95% confidence interval [CI], 1.14–1.75; <i>P</i> = 0.002). After full adjustment in the multivariable regression analysis, a unit increase in METS-VF was correlated with a 79% higher possibility of AVC new-onset (hazard ratio [HR] = 1.79; 95% CI, 1.24–2.59; <i>P</i> = 0.002) and an 86% higher incident of AVC progression (HR = 1.86; 95% CI, 1.41–2.44; <i>P</i> &lt; 0.001). Restricted cubic spline analysis revealed approximately linear relationships between METS-VF and AVC prevalence, new-onset, and progression. Subgroup analyses demonstrated consistent findings across groups, except for notable interactions by race (for AVC prevalence) and sex (for AVC new-onset). METS-VF outperformed other indices linked to anthropometric and metabolic characteristics in terms of predictive performance, based on receiver operating characteristic curves. Additionally, MR demonstrated that VAT had a strong causal effect on CAVS.</p> Conclusions <p>METS-VF independently predicts AVC prevalence, new-onset, and progression, and MR analyses support VAT as a causal factor for incident CAVS. METS-VF might function as an efficient and budget-friendly screening method or early risk identification. Targeting visceral adiposity represents a promising primary prevention strategy against valvular heart disease.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association of metabolic score for visceral fat with the prevalence, new-onset, and progression of aortic valve calcification: evidence from a prospective observational study and genetic analyses

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月27日

查看全文
  • Xingang Sun,
  • Hendsun Hendsun,
  • Ling Xia,
  • Lihong Wang,
  • Liuyang Wu

摘要

Background

Obesity significantly influences aortic valve calcification (AVC). However, the relationship between Metabolic Score for Visceral Fat (METS-VF), an indicator of visceral adiposity, and AVC remains largely unclear. Therefore, this study investigated the correlations between METS-VF with AVC prevalence, new-onset, and progression, as well as the causal association between visceral adipose tissue (VAT) and calcific aortic valve stenosis (CAVS).

Methods

The analysis included a cohort of 5,245 individuals drawn from the Multi-Ethnic Study of Atherosclerosis (MESA) database. Associations between baseline METS-VF and AVC prevalence, new-onset, and progression were analyzed through logistic regression and Cox regression. The potential causal link between the VAT and CAVS was evaluated by applying a two-sample Mendelian randomization (MR) strategy.

Results

The findings indicated that a one-unit increment in METS-VF correlates with a 41% increased risk of prevalent AVC in the fully adjusted model (odds ratio [OR] = 1.41; 95% confidence interval [CI], 1.14–1.75; P = 0.002). After full adjustment in the multivariable regression analysis, a unit increase in METS-VF was correlated with a 79% higher possibility of AVC new-onset (hazard ratio [HR] = 1.79; 95% CI, 1.24–2.59; P = 0.002) and an 86% higher incident of AVC progression (HR = 1.86; 95% CI, 1.41–2.44; P < 0.001). Restricted cubic spline analysis revealed approximately linear relationships between METS-VF and AVC prevalence, new-onset, and progression. Subgroup analyses demonstrated consistent findings across groups, except for notable interactions by race (for AVC prevalence) and sex (for AVC new-onset). METS-VF outperformed other indices linked to anthropometric and metabolic characteristics in terms of predictive performance, based on receiver operating characteristic curves. Additionally, MR demonstrated that VAT had a strong causal effect on CAVS.

Conclusions

METS-VF independently predicts AVC prevalence, new-onset, and progression, and MR analyses support VAT as a causal factor for incident CAVS. METS-VF might function as an efficient and budget-friendly screening method or early risk identification. Targeting visceral adiposity represents a promising primary prevention strategy against valvular heart disease.

Graphical Abstract